[1] 谭曼红,姜春燕,罗 佳. 雷贝拉唑致免疫介导性药物性肝损伤1例[J]. 肝脏,2014,16(2):175-176.
[2] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 中华肝脏病杂志,2015,23(11):810-820.
[3] Johnstone D, Berger C, Fleckman P, et al. Acute fulminant hepatitis after treatment with rabeprazole and terbinafine[J]. Arch Intern Med, 2001,161:1677-1678.
[4] Zaccardi F, Pitocco D, Martini L, et al. A case of esomeprazole-induced transient diabetes and hepatitis: the role of liver inflammation in the pathogenesis of insulin resistance [J]. Acta Diabetol, 2014, 51: 151-153.
[5] 董东方,王群英,钟慧闽. 埃索美拉唑镁致肝功能异常1例[J]. 山东医药, 2008, 48(4): 21.
[6] Gomez MR, Otero MA, Fobelo MJ, et al. Acute hepatitis related to omeprazole [J]. Am J Gastroenterol, 1999, 94(4): 1119-1120.